Novel Risk Markers and Risk Assessments for Cardiovascular Disease (vol 120, pg 133, 2017)

被引：0
|
作者：
Thomas
Lip
机构：
来源：
CIRCULATION RESEARCH | 2017年 / 120卷 / 07期
关键词：
D O I：
10.1161/RES.0000000000000142
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：E30 / E30
页数：1
相关论文
共 50 条
  • [41] Childhood Obesity, Diabetes, and Cardiovascular Disease Risk (vol 108, pg 3051, 2023)
    Salama, M.
    Balagopal, B.
    Fennoy, I
    Kumar, S.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (05): : e1422 - e1422
  • [42] Risk of cardiovascular disease and sudden death in schizophrenia (vol 63, pg 6, 2002)
    Davidson, M
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (08) : 744 - 744
  • [43] Genome-Wide Assessments of 138 Inflammatory Markers Identified Inflammatory Pathways Confer Cardiovascular Disease Risk
    Li, Jun
    Hu, Jie
    Han, Xikun
    Manson, Joann E.
    Hu, Frank B.
    Liang, Liming
    CIRCULATION, 2021, 144
  • [44] Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association (vol 119, pg 2408, 2009)
    Hlatky
    Hong, Yuling
    CIRCULATION, 2009, 119 (25) : E606 - E606
  • [45] Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments
    George B. Busby
    Scott Kulm
    Alessandro Bolli
    Jen Kintzle
    Paolo Di Domenico
    Giordano Bottà
    Nature Communications, 14
  • [46] Ancestry-specific polygenic risk scores are risk enhancers for clinical cardiovascular disease assessments
    Busby, George B.
    Kulm, Scott
    Bolli, Alessandro
    Kintzle, Jen
    Domenico, Paolo Di
    Botta, Giordano
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [47] Using run charts for cardiovascular disease risk assessments in general practice
    Wells, Susan
    Rafter, Natasha
    Eggleton, Kyle
    Turner, Catherine
    Huang, Ying
    Bullen, Chris
    JOURNAL OF PRIMARY HEALTH CARE, 2016, 8 (02) : 172 - 178
  • [48] Asymmetric dimethylarginine: a novel cardiovascular risk factor in end-stage renal disease (vol 40, pg 340, 2012)
    Alsagaff, M. Yusuf
    Thaha, M.
    Aminuddin, M.
    Yogiarto, R. M.
    Yogiantoro, M.
    Tomino, Y.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2012, 40 (02) : 832 - 832
  • [49] Risk stratification in cardiovascular disease primary prevention - scoring systems, novel markers, and imaging techniques
    Zannad, Faiez
    De Backer, Guy
    Graham, Ian
    Lorenz, Matthias
    Mancia, Giuseppe
    Morrow, David A.
    Reiner, Zeljko
    Koenig, Wolfgang
    Dallongeville, Jean
    Macfadyen, Robert J.
    Ruilope, Luis M.
    Wilhelmsen, Lars
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (02) : 163 - 174
  • [50] CARDIOVASCULAR RISK-FACTORS AND RISK ASSESSMENTS IN NORTHWEST SURVEY
    LARSEN, LH
    COMMUNITY HEALTH STUDIES, 1978, 2 (01): : 51 - 51
12345